SCHEMBL13664673

SCHEMBL13664673

CCCc1nsc(OC)n1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE3A Q14432 1/20 0.33
PDE10A Q9Y233 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21366417 0.83
SCHEMBL6531264 0.74
SCHEMBL20320427 0.71
SCHEMBL4442483 0.70
SCHEMBL4939076 0.70
SCHEMBL8901436 0.66
SCHEMBL10920679 0.64 CYP1A2 (0.44)
SCHEMBL14272702 0.64
SCHEMBL11604727 0.64
SCHEMBL6309848 0.63 IKBKB (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009124756-A1 USE OF APREPITANT AND DERIVATIVES THEREOF FOR THE TREATMENT OF CANCER EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) 2009-10-15 WO disclosed